1.
Strecker J, Jones S, Koopal B, et al. Engineering of CRISPR-Cas12b for human genome editing. Nat Commun. 2019;10(1):212. doi:10.1038/s41467-018-08224-4.
1.
Hu JH, Miller SM, Geurts MH, et al. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature. 2018;556(7699):57-63. doi:10.1038/nature26155.
1.
Henn MR, Sullivan MB, Stange-Thomann N, et al. Analysis of high-throughput sequencing and annotation strategies for phage genomes. PLoS One. 2010;5(2):e9083. doi:10.1371/journal.pone.0009083.
1.
Woods IG, Schier AF. Targeted mutagenesis in zebrafish. Nat Biotechnol. 2008;26(6):650-1. doi:10.1038/nbt0608-650.
1.
Hsu PD, Scott DA, Weinstein JA, et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 2013;31(9):827-32. doi:10.1038/nbt.2647.
1.
Ran A, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281-308. doi:10.1038/nprot.2013.143.
1.
Hwang WY, Peterson RT, Yeh J-RJ. Methods for targeted mutagenesis in zebrafish using TALENs. Methods. 2014;69(1):76-84. doi:10.1016/j.ymeth.2014.04.009.
1.
Cox DBT, Platt RJ, Zhang F. Therapeutic genome editing: prospects and challenges. Nat Med. 2015;21(2):121-31. doi:10.1038/nm.3793.
1.
Hubbard BP, Badran AH, Zuris JA, et al. Continuous directed evolution of DNA-binding proteins to improve TALEN specificity. Nat Methods. 2015;12(10):939-42. doi:10.1038/nmeth.3515.
1.
Guilinger JP, Pattanayak V, Reyon D, et al. Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity. Nat Methods. 2014;11(4):429-35. doi:10.1038/nmeth.2845.